National Breast and Ovarian Cancer Centre (NBOCC)

Linking health professionals to the latest research

Recent Research is produced by National Breast Cancer and Ovarian Cancer Centre (NBOCC) as a service for health professionals, to highlight research of interest or potential significance featured in peer-reviewed publications. Recent Research aims to keep you in touch with some of the latest published research that may be of interest. NBOCC does not necessarily endorse the views or conclusions of any of the papers listed below.

This service provides a link to abstracts only; full-text of the articles are not provided by NBOCC and must be accessed using individual or institutional subscriptions.

Editor: Dr Anne Nelson, Evidence Review and Research Leader, NBOCC

February 2010

Migraine History and Breast Cancer Risk Among Postmenopausal Women
Li CI.,  Mathes RW., Bluhm EC., et al. J Clin Oncol 2010;28:1005-1010.
Abstract

 Disparities in access to breast care nurses for breast surgeons: A National Breast Cancer Audit survey. Marsh C, Wang J, Kollias J., et al. Breast epub Feb 19 2010 doi: 10.1016/j.breast.2010.01.003
Abstract

Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial. Kuhl C., Weigel S., Schrading S., et al. J Clin Oncol epub 22 February 2010 doi:10.1200/JCO.2009.23.0839
Abstract

First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Cardiac Safety and Efficacy Data From the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) Trial. Untch M., Muscholl M., Tjulandin S., et al. J Clin Oncol epub 22 February 2010 doi:10.1200/JCO.2009.21.9709
Abstract

The rise and fall in menopausal hormone therapy and breast cancer incidence. Pelucchi C., Levi F., La Vecchia C. Breast epub 20 Feb 2010 doi:10.1016/j.breast.2010.01.021
Abstract

Estimation of an optimal chemotherapy utilisation rate for breast cancer: Setting an evidence-based benchmark for the best-quality cancer care. Ng W., Delaney GP., Jacob S., Eur J Cancer 2010;46(4):703-712
Abstract

Surveillance for the detection of recurrent ovarian cancer: Survival impact or lead-time bias?
Tanner EJ., Chi DS., Eisenhauer EL., et al. Gynecol Oncol epub 10 Feb 2010 doi:10.1016/j.ygyno.2010.01.014
Abstract

Life is precious and I'm making the best of it: coping strategies of long-term cancer survivors. Zucca AC., Boyes AW., Lecathelinais C., et al. Psycho oncology epub 11 February 2010 doi: 10.1002/pon.1686  
Abstract

The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study. Chan JK., Tian C., Fleming GF., et al. Gynecol Oncol 116(3):301-6
Abstract

Predictive Value of Symptoms for Early Detection of Ovarian Cancer. Rossing MA., Wicklund KG., Cushing-Haugen KL., et al. J Natl Cancer Inst 2010;102:236–243.
Abstract

Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen. Dowsett M., Cuzick J., Ingle J., et al. J Clin Oncol 2010;28(3):509-18.
Abstract

Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among U.S. Women. Waters EA., Cronin KA., Graubard BI., et al. Cancer Epidemiol Biomarkers Prev 2010;19:443-6.
Abstract

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-megative cohort. Gianni L., Eiermann W., Semiglazov V., et al. Lancet 2010;375:377-84.
Abstract

January 2010

Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case – Control Study Anderson GL., McIntosh M., Wu L., et al. J Natl Cancer Inst 2010;102:26–38

Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. Torres Lacomba M., Yuste Sànchez MJ., Zapico Goni A., et al. BMJ 2010;340:b5396

Abstract

Patterns of Surgical Treatment for Women with Breast Cancer in Relation to Age. Wang J., Kollias J., Boult M., et al. Breast Journal 2010;16(1):60-65.  

Abstract

Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials. Valachis A., Polyzos NP., Patsopoulos NA., et al. Breast Cancer Res Treat epub 9^th Jan 2010 doi: 10.1007/s10549-009-0727-0

Abstract

 Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes. Virnig BA., Tuttle TM., Shamliyan T., et al. J Natl Cancer Inst. 2010;102:170–178: 

Abstract